“When we were doing due diligence on acquiring camlipixant we looked at Merck’s program and it was pretty clear there was a number of things that we could build into our phase 3 program to reduce and ...
OKLAHOMA CITY - Devyn Galmor knew it wasn't just reflux causing her infant son to suffer. Seeking a second opinion, Galmor took the 5-week-old Cullen to The Children's Hospital at OU Medical Center on ...
Reaffirms guidance for the Phase 2a RIVER trial in refractory chronic cough and Human Abuse Potential (HAP) Study with topline data for each expected in the second half of 2024 Topline results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback